Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02523443 · ClinicalTrials.gov registry record · Phase 3
Patient Controlled Epidural Analgesia Versus Intravenous Patient Controlled Analgesia for Post-Operative Pain Control in Patients Undergoing Elective Liver Resection
A Phase 3 study of Liver Cancer and Pain Management, sponsored by Memorial Sloan Kettering Cancer Center.
- Active
- Registry status
- Phase 3
- Development phase
- 231
- Enrollment target
- 3
- Study locations
NCT02523443 is a Phase 3 study of Liver Cancer and Pain Management that is active but no longer recruiting, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 231 participants, below the 445-participant average among 78 other Liver Cancer trials with a reported enrollment target (48% lower). The trial reports 3 study locations across 2 states.
The verdict
NCT02523443, a Phase 3 study of Liver Cancer and Pain Management, is active but no longer recruiting, sponsored by Memorial Sloan Kettering Cancer Center.
- ACTIVE NOT RECRUITING
- Registry status
- Phase 3
- Development phase
- 231 participants
- Enrollment target
- 3
- Study locations
Study Summary
The purpose of this study is to learn whether patient-controlled epidural analgesia (PCEA) is a better method for managing pain after liver resection compared to patient-controlled analgesia (IV PCA). Currently, the standard pain control method for liver resection patients is IV PCA. There is not enough data on how epidural (PCEA) relieves pain and movement on a day to day basis after liver resection.
Conditions Studied
Interventions
- OTHER IV PCA
- OTHER PCEA
Study Locations (3)
New York
- Memorial Sloan Kettering Cancer Center @ Commack (Consent Only) - Commack
- Memorial Sloan Kettering Cancer Center - New York
New Jersey
- Memorial Sloan Kettering Cancer Center (Consent Only) - Basking Ridge
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 231 participants |
| Start Date | 2015-08 |
| Est. Completion | 2026-08 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02523443
The ClinicalTrials.gov registry entry for NCT02523443 describes a study currently listed as active not recruiting, categorized as Phase 3. The registered enrollment target is 231 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 445-participant average among 78 other Liver Cancer trials with a reported enrollment target (48% lower). The listed sponsor is Memorial Sloan Kettering Cancer Center, which has 1,884 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Liver Cancer appearing as the primary indexed condition, and to 2 interventions - of which IV PCA is the first listed.
NCT02523443 reports 3 study locations spanning 2 distinct geographic areas - top geographies include New York, New Jersey.
Frequently Asked Questions
What is clinical trial NCT02523443 about?
NCT02523443 is a clinical study titled "Patient Controlled Epidural Analgesia Versus Intravenous Patient Controlled Analgesia for Post-Operative Pain Control in Patients Undergoing Elective Liver Resection". The purpose of this study is to learn whether patient-controlled epidural analgesia (PCEA) is a better method for managing pain after liver resection compared to patient-controlled analgesia (IV PCA). Currently, the standard pain control method for liver resection patients is IV PCA. There is not en...
What is the current status of trial NCT02523443?
This trial is currently active not recruiting. It is a Phase 3 study. The enrollment target is 231 participants. The study started on 2015-08. Estimated completion is 2026-08.
What conditions does trial NCT02523443 study?
This clinical trial studies the following conditions: Liver Cancer, Pain Management.
What interventions are being tested in trial NCT02523443?
The interventions under investigation include: IV PCA (OTHER), PCEA (OTHER).
Who is sponsoring clinical trial NCT02523443?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02523443 being conducted?
This trial has 3 study locations across New Jersey, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Liver Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Study of Nivolumab in Participants With Hepatocellular Carcinoma Who Are at High Risk of Recurrence After Curative Hepatic Resection or Ablation
ACTIVE NOT RECRUITING · Phase 3
-
Early Palliative Care With Standard Care or Standard Care Alone in Improving Quality of Life of Patients With Incurable Lung or Non-colorectal Gastrointestinal Cancer and Their Family Caregivers
COMPLETED · Phase 3
-
Feasibility Study of CBCT for IGRT in Cancer Patients
RECRUITING · NA
-
Collection of Blood From Patients With Cancer
RECRUITING
-
National Liver Cancer Screening Trial
RECRUITING · Phase 4
-
vGRID SBRT: A Phase I Clinical Trial in Unresectable or Metastatic HCC
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.